TCM
MRNA icon

TruNorth Capital Management’s Moderna MRNA Stock Holding History

TruNorth Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4
Closed -$103 – 285
2025
Q3 		$103 Hold
4
– – ﹤0.01% 406
2025
Q2 		$110 Hold
4
– – ﹤0.01% 351
2025
Q1 		$113 Hold
4
– – ﹤0.01% 432
2024
Q4 		$166 Hold
4
– – ﹤0.01% 370
2024
Q3 		$267 Hold
4
– – ﹤0.01% 384
2024
Q2 		$475 Hold
4
– – ﹤0.01% 339
2024
Q1 		$426 Buy
+4
New +$403 ﹤0.01% 260

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

TruNorth Capital Management's MRNA Position: Q4 2025 in Review

TruNorth Capital Management sold out of Moderna (MRNA) in Q4 2025, closing a stake of 4 shares — an estimated $103 sold.

TruNorth Capital Management first reported a position in MRNA in Q1 2024 and held it in 7 quarters. The position peaked at $475 in Q2 2024. 673 funds tracked by Wall St. Rank hold MRNA as of Q4 2025.

  • TruNorth Capital Management reported no remaining Moderna position as of Q4 2025 after selling out during the quarter.
  • TruNorth Capital Management sold 4 Moderna shares in Q4 2025, an estimated $103.
  • TruNorth Capital Management first reported a position in Moderna in Q1 2024 and held it in 7 quarters.
  • TruNorth Capital Management's Moderna position peaked at $475 in Q2 2024.
  • 673 funds tracked by Wall St. Rank held Moderna as of Q4 2025.

Based on TruNorth Capital Management's 13F filing for Q4 2025, filed 11 Feb 2026.